Drug Discovery Core at the Medical University of South Carolina

Therapeutic Approaches: Small Molecules, Biomarkers,

Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Regenerative Medicine

Center/Program Highlights:

The Medical University of South Carolina (MUSC) is an ideal research environment to connect patient needs, clinical practices, and innovative drug discovery to develop effective treatments for complex diseases. The MUSC Drug Discovery Core (DDC) is a specialized resource providing tools, facilities, and expertise for therapeutic development, chemical biology, and translational science. The DDC strives to link together the pharmacology and medicinal chemistry of cell signaling, and cheminformatics through thoughtful study of the effects and properties of chemicals and proteins for researchers and biotechnology companies in South Carolina.

The primary goal of the DDC is to facilitate the discovery of new chemical probes with the focused vision of creating experimental therapeutics.

Another goal of the DDC is education by providing students the opportunity to learn innovative techniques while doing real world experimentation is critical to the mission of MUSC and the DDC.

The mission of the DDC is to keep MUSC abreast of and competitive in the areas of academic drug discovery, medicinal chemistry, target engagement, cheminformatics, and generation of intellectual property.

Sources of Funding: University, Revenue, Federal/State,


Institutional Affiliation(s): Medical University of South Carolina

70 President Street, Room 404
MSC 139
South Carolina, 29425
United States

Center/Program Start Date: 2011

Number of Employees: 4